The Analyst Verdict: Biogen In The Eyes Of 12 Experts

Jul 29, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Biogen, presenting an average target of $311.58, a high estimate of $342.00, and a low estimate of …

CouponFollow Extension

$311.58
OFF

The Analyst Verdict: Biogen In The Eyes Of 12 Experts

1 day from now

Jul 29, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Biogen, presenting an average target of $311.58, a high estimate of $342.00, and a low estimate of …

nasdaq.com

$262.63
OFF

The Latest Analyst Ratings For Biogen - Nasdaq

1 day from now

Oct 10, 2024 · Analysts have recently evaluated Biogen and provided 12-month price targets. The average target is $262.63, accompanied by a high estimate of $302.00 and a low estimate of …

nasdaq.com

$73.71
OFF

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts

1 day from now

13 hours ago · Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $73.71, a high estimate of $90.00, and a low estimate of $63.00.

benzinga.com

$280.81
OFF

The Analyst Landscape: 27 Takes On Biogen | Markets Insider

1 day from now

Apr 29, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $280.81, a high estimate of $364.00, and a low estimate of $200.00.

businessinsider.com

$299.05
OFF

A Closer Look At 21 Analyst Recommendations For Biogen

1 day from now

Mar 5, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $299.05, a high estimate of $364.00, and a low estimate of $240.00. ... The analysis …

businessinsider.com

$73.71
OFF

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 …

1 day from now

1 day ago · Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $73.71, a high estimate of $90.00, and a low estimate of $63.00. This current …

inkl.com

$87
OFF

The Analyst Verdict: Ambarella In The Eyes Of 4 Experts

1 day from now

17 hours ago · The Analyst Verdict: Ambarella In The Eyes Of 4 Experts ... through their assessments of 12-month price targets, revealing an average target of $87.5, a high estimate …

benzinga.com

19%
OFF

Biogen Idec Inc. (NASDAQ:BIIB) - If You Invested $100 In

1 day from now

Dec 26, 2023 · Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 3.19% on an annualized basis producing an average annual return of 10.72%.Currently, …

benzinga.com

$49.65
OFF

The Analyst Verdict: Comcast In The Eyes Of 15 Experts

1 day from now

Nov 20, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $49.65, a high estimate of $60.00, and a low estimate of $40.00.

benzinga.com

$40
OFF

The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts

1 day from now

Oct 29, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $40.4, a high estimate of $50.00, and a low estimate of $20.00.

benzinga.com

$1069.69
OFF

The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 13 …

1 day from now

Jun 24, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Regeneron Pharmaceuticals, presenting an average target of $1069.69, a high estimate of …

nasdaq.com

$78.25
OFF

The Analyst Verdict: Bank Of New York Mellon In The Eyes Of 12 …

1 day from now

Nov 11, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $78.25, a high estimate of $86.00, and a low estimate of $66.00.

benzinga.com

$87
OFF

The Analyst Verdict: Ambarella In The Eyes Of 4 Experts - Inkl

1 day from now

1 day ago · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $87.5, a high estimate of $100.00, and a low estimate of …

inkl.com

$156.33
OFF

The Analyst Verdict: NVIDIA In The Eyes Of 33 Experts

1 day from now

Nov 11, 2024 · The Analyst Verdict: NVIDIA In The Eyes Of 33 Experts ... Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $156.33, with …

nasdaq.com

$91.81
OFF

The Analyst Verdict: Coherent In The Eyes Of 21 Experts

1 day from now

Nov 7, 2024 · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $91.81, with a high estimate of $125.00 and a low estimate of $50.00.

benzinga.com

FAQs about The Analyst Verdict: Biogen In The Eyes Of 12 Experts Coupon?

How do financial analysts perceive Biogen?

Financial analysts' perception of Biogen is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. ...

What is the average price target for Biogen?

In the assessment of 12-month price targets, analysts unveil insights for Biogen, presenting an average target of $311.58, a high estimate of $342.00, and a low estimate of $294.00. This current average represents a 1.03% decrease from the previous average price target of $314.82. Diving into Analyst Ratings: An In-Depth Exploration ...

What does a Biogen analyst do?

Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Biogen compared to the broader market. Price Targets: Analysts predict movements in price targets, offering estimates for Biogen's future value. ...

How do analysts predict Biogen's future value?

Price Targets: Analysts predict movements in price targets, offering estimates for Biogen's future value. Examining the current and prior targets offers insights into analysts' evolving expectations. ...

How do analysts evaluate Biogen's stock price?

Analysts evaluate Biogen's stock by setting price targets, which provide estimates for the future value of the company's stock. Comparing these price targets reveals trends in analysts' expectations over time. Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Biogen's market standing. ...

How do analysts react to Biogen's latest developments?

Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Biogen. This information provides a snapshot of how analysts perceive the current state of the company. ...